Exploring new ways to improve liver cancer treatment for American Indians and Alaska Natives.
Developmental Research Program
This study is looking for new ways to better detect and treat liver cancer, especially for American Indian and Alaska Native communities, so that patients can have better care and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10706329 on NIH RePORTER |
What this research studies
This research program focuses on developing innovative projects aimed at enhancing our understanding and treatment of hepatocellular carcinoma (HCC), particularly among American Indian and Alaska Native populations. By supporting early-phase research, the program seeks to identify effective strategies for early detection, prevention, and treatment of liver cancer. The approach includes collaboration between various institutions to leverage resources and expertise, ultimately aiming to reduce health disparities and improve patient outcomes. Patients may benefit from advancements in liver cancer care that arise from these developmental projects.
Who could benefit from this research
Good fit: Ideal candidates for this research are American Indians and Alaska Natives who are at risk for or diagnosed with hepatocellular carcinoma.
Not a fit: Patients who do not belong to the American Indian or Alaska Native populations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better health outcomes for patients with liver cancer.
How similar studies have performed: Previous research has shown promise in addressing health disparities in cancer treatment, indicating that this approach could yield significant advancements.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Ioannou, George — University of Washington
- Study coordinator: Ioannou, George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.